Feldan Therapeutics Overview
- Year Founded
-
2007
- Status
-
Private
- Employees
-
37
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$23.3M
- Investors
-
13
Feldan Therapeutics General Information
Description
Operator of intracellular delivery technology intended to enable targeted delivery of therapeutics into cells. The company's platform offers peptide-based delivery mechanisms for antisense oligonucleotides and access to intracellular targets, enabling pharmaceutical and biotechnology organizations to develop therapies targeting previously inaccessible cellular processes.
Contact Information
Website
www.feldan.comCorporate Office
- 2666 Boulevard Du Parc Technologique
- Suite 290
- Quebec, Quebec G1P 4S6
- Canada
Corporate Office
- 2666 Boulevard Du Parc Technologique
- Suite 290
- Quebec, Quebec G1P 4S6
- Canada
Feldan Therapeutics Timeline
Feldan Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC (Series B) | 08-Aug-2024 | $23.3M | Completed | Pre-Clinical Trials | ||
| 7. Grant | 28-Aug-2023 | Completed | Clinical Trials - Phase 1 | |||
| 6. Grant | 26-Jun-2023 | Completed | Clinical Trials - Phase 1 | |||
| 5. Later Stage VC (Series A) | 31-Aug-2018 | Completed | Pre-Clinical Trials | |||
| 4. Later Stage VC | 24-Jul-2015 | Completed | Pre-Clinical Trials | |||
| 3. Angel (individual) | 24-Apr-2013 | Completed | Pre-Clinical Trials | |||
| 2. Angel (individual) | 19-Jul-2011 | $500K | $1M | Completed | Pre-Clinical Trials | |
| 1. Angel (individual) | 09-Dec-2010 | $500K | $500K | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Feldan Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Feldan Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Feldan Therapeutics Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Amgen Ventures | Corporate Venture Capital | Minority | ||
| Fonds de solidarite FTQ | PE/Buyout | Minority | ||
| Genesys Capital | Venture Capital | Minority | ||
| Investissement Quebec | PE/Buyout | Minority | ||
| Linearis | Venture Capital | Minority |
Feldan Therapeutics FAQs
-
When was Feldan Therapeutics founded?
Feldan Therapeutics was founded in 2007.
-
Where is Feldan Therapeutics headquartered?
Feldan Therapeutics is headquartered in Quebec, Canada.
-
What is the size of Feldan Therapeutics?
Feldan Therapeutics has 37 total employees.
-
What industry is Feldan Therapeutics in?
Feldan Therapeutics’s primary industry is Drug Delivery.
-
Is Feldan Therapeutics a private or public company?
Feldan Therapeutics is a Private company.
-
What is the current valuation of Feldan Therapeutics?
The current valuation of Feldan Therapeutics is .
-
What is Feldan Therapeutics’s current revenue?
The current revenue for Feldan Therapeutics is .
-
How much funding has Feldan Therapeutics raised over time?
Feldan Therapeutics has raised $39.2M.
-
Who are Feldan Therapeutics’s investors?
Amgen Ventures, Fonds de solidarite FTQ, Genesys Capital, Investissement Quebec, and Linearis are 5 of 13 investors who have invested in Feldan Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
